Financing ·
At the 2026 Annual Meeting of Stockholders held on July 15, 2026, Cosmos Health Inc. stockholders approved the…
COSMCosmos Health Inc.
At the 2026 Annual Meeting of Stockholders held on July 15, 2026, Cosmos Health Inc. stockholders approved the designation and issuance of 100,000 shares of Series B Preferred Stock. The meeting also resulted in the election of six directors, including Grigorios Siokas and Theodoros C. Karkantzos, and the ratification of its independent registered public accounting firm. Cosmos Health Inc. operates in the healthcare sector and provides various health-related products and services.